Back to results
CompletedN/A

Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ

NCT00555152

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Alabama at Birmingham Cancer Center

Birmingham, Alabama, United States

+1 additional location

View on ClinicalTrials.gov
Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ — TrialFind